{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:01:13Z","timestamp":1790874073360,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>To systematically evaluate the clinical efficacy and safety of a Gegen Qinlian decoction combined with mesalazine for the treatment of ulcerative colitis (UC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Chinese (CNKI, CSPD, CCD, and CBM) and foreign databases (PubMed, Web of Science, Cochrane Library, and Embase) were searched for randomized controlled trials related to the treatment regimen used in this study. The risk of bias of the included studies was evaluated using the Cochrane assessment tool. Revman5.0 and Stata17.0 were used for the meta-analysis and sensitivity analysis. Trial sequential analysis was used for sequential analysis. Gradepro3.6 was used to evaluate the level of evidence quality of outcome indicators.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Fifteen studies involving 1428 patients were included. The results of meta-analysis showed that the intervention group in the treatment of UC improved the total clinical effective rate (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001, relative risk\u2005=\u20051.22, 95% confidence interval (CI) [1.16\u20131.28]), the main clinical symptoms (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001, standard mean difference [SMD]\u2005=\u20051.58, 95% CI [1.86, 1.30]), intestinal mucosal barrier function (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001, SMD\u2005=\u20051.02, 95% CI [1.20, 0.84]), reduce the incidence of adverse reactions (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.05, relative risk\u2005=\u20050.59, 95% CI [0.35, 1.00]), modified Mayo score (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001, SMD\u2005=\u20051.53, 95% CI [2.17, 0.89]), Baron endoscopic score (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001, SMD\u2005=\u20050.93, 95 CI [1.18, 0.68]), regulate immune function (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001, SMD\u2005=\u20050.69, 95% CI [0.47, 0.90]), inflammatory factor levels (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001, SMD\u2005=\u20050.69, 95% CI [0.47, 0.90]), intestinal flora (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.004, SMD\u2005=\u20051.42, 95% CI [0.44, 2.39]), the intervention group were better than the comparison group. But there was no significant difference in oxidative stress index (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.54, SMD\u2005=\u2005-0.44, 95% CI [-1.82, 0.95]).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Gegen Qinlian decoction combined with mesalazine has definite clinical efficacy and safety for the treatment of UC. Owing to the limited methodological quality of the included studies, high-quality randomized controlled trials are still needed for verification in the future.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000042266","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T10:00:50Z","timestamp":1753956050000},"page":"e42266","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of Gegen Qinlian decoction combined with mesalazine for the treatment of UC: A meta-analysis and systematic review"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7412-9727","authenticated-orcid":false,"given":"Yanjie","family":"Chen","sequence":"first","affiliation":[{"name":"The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoqi","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Yuan","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haomin","family":"He","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yuan","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyin","family":"Xiao","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yile","family":"Qin","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lian","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3214-9247","authenticated-orcid":false,"given":"Zhouyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Changsha Hospital of Traditional Chinese Medicine (Changsha Eighth Hospital), Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251014","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.3390\/nu15163572","article-title":"Malnutrition defined by the global leadership initiative on malnutrition (GLIM) criteria in hospitalized patients with ulcerative colitis and its association with clinical outcomes.","volume":"15","author":"Wei","year":"2023","journal-title":"Nutrients"},{"key":"R2-20251014","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis.","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"R3-20251014","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2147\/CLEP.S402718","article-title":"Temporal trends of inflammatory bowel disease burden in china from 1990 to 2030 with comparisons to Japan, South Korea, the European Union, the United States of America, and the world.","volume":"15","author":"Ma","year":"2023","journal-title":"Clin Epidemiol"},{"key":"R4-20251014","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ueg2.12319","article-title":"Environmental risk factors for inflammatory bowel disease.","volume":"10","author":"Singh","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"R5-20251014","doi-asserted-by":"crossref","first-page":"103017","DOI":"10.1016\/j.autrev.2021.103017","article-title":"The influence of cytokines on the complex pathology of ulcerative colitis.","volume":"21","author":"Nakase","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"Suppl 1","key":"R6-20251014","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000504092","article-title":"Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology. Treatment algorithm for mild and moderate-to-severe ulcerative colitis: an update.","volume":"101","author":"Burri","year":"2020","journal-title":"Digestion"},{"key":"R7-20251014","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","article-title":"Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis.","volume":"156","author":"Paramsothy","year":"2019","journal-title":"Gastroenterology"},{"key":"R8-20251014","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1136\/gutjnl-2022-327811","article-title":"Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial.","volume":"71","author":"Kedia","year":"2022","journal-title":"Gut"},{"key":"R9-20251014","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1053\/j.gastro.2022.02.033","article-title":"Higher vs standard adalimumab induction and maintenance dosing regimens for treatment of ulcerative colitis: SERENE UC trial results.","volume":"162","author":"Pan\u00e9s","year":"2022","journal-title":"Gastroenterology"},{"key":"R10-20251014","doi-asserted-by":"crossref","first-page":"103751","DOI":"10.1016\/j.ebiom.2021.103751","article-title":"MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis.","volume":"74","author":"Yao","year":"2021","journal-title":"EBioMedicine"},{"key":"R11-20251014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bpg.2018.05.017","article-title":"Surgery in ulcerative colitis: When? How?","volume":"32-33","author":"Gallo","year":"2018","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R12-20251014","first-page":"944","article-title":"Review on the research progress of traditional Chinese medicine in the treatment of ulcerative colitis.","volume":"41","author":"Zhang","year":"2012","journal-title":"Beijing Tradit Chin Med"},{"key":"R15-20251014","first-page":"182","article-title":"Effect analysis of Gegen Qinlian decoction combined with mesalazine on ulcerative colitis.","volume":"13","author":"Bian","year":"2015","journal-title":"J Contemp Med"},{"key":"R16-20251014","first-page":"89","article-title":"Curative effect of Gegen Qinlian decoction on ulcerative colitis and its influence on inflammatory response and immune function.","volume":"30","author":"Gao","year":"2018","journal-title":"Chinese PLA Med J"},{"key":"R17-20251014","first-page":"25","article-title":"Clinical observation of modified Gegen Qinlian decoction combined with mesalazine in the treatment of damp-heat ulcerative colitis.","volume":"37","author":"Gu","year":"2021","journal-title":"Shanxi Tradit Chin Med"},{"key":"R18-20251014","first-page":"118","article-title":"Clinical effect of modified Gegen Qinlian decoction combined with mesalazine in the treatment of ulcerative colitis with large intestine damp-heat and its regulation of intestinal flora, immune function and inflammation level.","volume":"42","author":"Long","year":"2024","journal-title":"Chin J Tradit Chin Med"},{"key":"R19-20251014","first-page":"21","article-title":"Clinical efficacy of Gegen Qinlian decoction combined with mesalazine in the treatment of ulcerative colitis.","volume":"33","author":"Shen","year":"2023","journal-title":"Shenzhen J Integr Tradit Chin West Med"},{"key":"R20-20251014","first-page":"127","article-title":"Effect of modified Gegen Qinlian decoction combined with western medicine on severe ulcerative colitis.","volume":"41","author":"Wang","year":"2023","journal-title":"Sichuan Tradit Chin Med"},{"key":"R21-20251014","first-page":"2625","article-title":"Effect of Gegen Qinlian decoction combined with solution-focused nursing model on immune function and inflammatory response in patients with acute ulcerative colitis.","volume":"36","author":"Song","year":"2021","journal-title":"Guangming Tradit Chin Med"},{"key":"R22-20251014","first-page":"141","article-title":"Curative effect of Gegen Qinlian decoction combined with mesalazine on ulcerative colitis and its effect on inflammatory factors in patients.","volume":"36","author":"Zhong","year":"2023","journal-title":"Med Inf"},{"key":"R24-20251014","first-page":"38","article-title":"Clinical study of Huidi oral combined with Gegen Qinlian decoction retention enema in the treatment of 67 cases of damp-heat type ulcerative colitis.","volume":"31","author":"Xi","year":"2011","journal-title":"Chin J Anorectal"},{"key":"R25-20251014","first-page":"140","article-title":"Effect and mechanism of modified Gegen Qinlian decoction on mild to moderate ulcerative colitis with damp-heat accumulation.","volume":"19","author":"Yang","year":"2021","journal-title":"Chin Prescription Med"},{"key":"R26-20251014","first-page":"92","article-title":"Effect of modified Gegen Qinlian decoction on immune function and intestinal mucosal barrier function in patients with severe damp-heat type ulcerative colitis.","volume":"50","author":"Yang","year":"2023","journal-title":"Liaoning J Tradit Chin Med"},{"key":"R27-20251014","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/CM9.0000000000000614","article-title":"Clinical effect of modified Gegen Qinlian decoction combined with conventional treatment on patients with severe damp-heat type ulcerative colitis.","volume":"42","author":"Zhang","year":"2020","journal-title":"Chin Pat Med"},{"key":"R28-20251014","first-page":"605","article-title":"Effect of modified Gegen Qinlian decoction enema on ulcerative colitis of damp-heat accumulation type.","volume":"10","author":"Zhang","year":"2012","journal-title":"Seeking Med Advice (Acad Edn)"},{"key":"R29-20251014","first-page":"123","article-title":"Clinical effect of modified Gegen Qinlian decoction combined with mesalazine in the treatment of ulcerative colitis.","volume":"13","author":"Zhong","year":"2021","journal-title":"Clin Res Chin Med"},{"key":"R30-20251014","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S2468-1253(18)30231-0","article-title":"Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses.","volume":"3","author":"Nguyen","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R31-20251014","first-page":"239","article-title":"Research progress of Gegen Qinlian decoction and its modified decoction in the treatment of ulcerative colitis.","volume":"29","author":"Zhao","year":"2023","journal-title":"Chin J Exp Formulary"},{"key":"R32-20251014","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jep.2014.12.042","article-title":"Active components alignment of Gegen Qinlian decoction protects ulcerative colitis by attenuating inflammatory and oxidative stress.","volume":"162","author":"Xu","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"R34-20251014","first-page":"186","article-title":"Research progress of Gegen Qinlian decoction in the treatment of ulcerative colitis based on cell signaling pathway.","volume":"27","author":"Ma","year":"2021","journal-title":"Chin J Exp Formulary"},{"key":"R35-20251014","first-page":"3619","article-title":"Analysis of compatibility mechanism of Gegen Qinlian decoction in the treatment of ulcerative colitis based on network pharmacology.","volume":"47","author":"Li","year":"2022","journal-title":"Chin J Materia Medica"},{"key":"R36-20251014","first-page":"403","article-title":"Study on the mechanism of Gegen Qinlian Decoction in the treatment of ulcerative colitis based on network pharmacology.","volume":"28","author":"Zhang","year":"2020","journal-title":"Chin J Integr Tradit West Med Digestion"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T17:02:04Z","timestamp":1760461324000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":32,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042266","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"2023-11-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}